相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme
D. M. Moore et al.
HIV MEDICINE (2010)
Cohort Profile: The Canadian HIV-Hepatitis C Co-infection Cohort Study
Marina B. Klein et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C
Eugenia Vispo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers
M. Sanchez-Conde et al.
JOURNAL OF VIRAL HEPATITIS (2010)
Interruption of antiretroviral therapy is associated with increased plasma cystatin C
Amanda Mocroft et al.
AIDS (2009)
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial
Alexandra Calmy et al.
AIDS (2009)
Fast Fibrosis Progression Between Repeated Liver Biopsies in Patients Coinfected with Human Immunodeficiency Virus/Hepatitis C Virus
Juan Macias et al.
HEPATOLOGY (2009)
Incidence and Risk Factors of Thrombocytopenia in Patients Receiving Intermittent Antiretroviral Therapy: A Substudy of the ANRS 106-Window Trial
Marie-Anne Bouldouyre et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Influence of repeated cycles of structured therapy interruption on the rate of recovery of CD4+ T cells after highly active antiretroviral therapy resumption
Agathe Leon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen
Zoe Fox et al.
AIDS (2008)
Opportunistic Disease and Mortality in Patients Coinfected with Hepatitis B or C Virus in the Strategic Management of Antiretroviral Therapy (SMART) Study
Ellen Tedaldi et al.
CLINICAL INFECTIOUS DISEASES (2008)
Metabolic and Immune Activation Effects of Treatment Interruption in Chronic HIV-1 Infection: Implications for Cardiovascular Risk
Pablo Tebas et al.
PLOS ONE (2008)
Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression
Peter Bacchetti et al.
BMC INFECTIOUS DISEASES (2007)
Liver biopsy assessment in chronic hepatitis
Jay H. Lefkowitch
ARCHIVES OF MEDICAL RESEARCH (2007)
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy
Viviane D. Lima et al.
AIDS (2007)
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients
Lidia Ruiz et al.
AIDS (2007)
Highly active antiretroviral therapy interruption: Predictors and virologic and immunologic consequences
Giota Touloumi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Liver-related deaths in persons infected with the human immunodeficiency virus -: The D:A:D study
Rainer Weber
ARCHIVES OF INTERNAL MEDICINE (2006)
CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial):: a randomised trial
Christine Danel et al.
LANCET (2006)
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy
N Brau et al.
JOURNAL OF HEPATOLOGY (2006)
HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease
D Nunes et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
A Mocroft et al.
AIDS (2005)
Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients
H Al-Mohri et al.
HIV MEDICINE (2005)
Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: The SHASTA index
TB Kelleher et al.
JOURNAL OF HEPATOLOGY (2005)
Interruption of highly active antiretroviral therapy in HIV clinical practice - Results from the Italian cohort of antiretroviral-naive patients
AD Monforte et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy
D Fuster et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection
N Qurishi et al.
LANCET (2003)
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
CT Wai et al.
HEPATOLOGY (2003)
Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus
M Puoti et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure
V Miller et al.
AIDS (2000)
Marginal structural models and causal inference in epidemiology
JM Robins et al.
EPIDEMIOLOGY (2000)
Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men
MA Hernan et al.
EPIDEMIOLOGY (2000)
分享论文
